RecruitingPhase NA

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

The 'Power of Pork Protein' (From Diverse Pork Products) to Promote Health and Well-being During GLP-1 Medication Use in Middle-aged Women (With Overweight/Obesity)

Lead sponsor

University of Texas at Austin

Asset

GLP-1 / incretin class catch-all

Listed sites

Recruiting sites

Estimated enrollment

Study population

Obesity / overweight

Eligibility highlights

•BMI ≥25•Female•Healthy volunteers

Primary endpoints

•Body Composition•Muscle Mass•3-day Average Daily Intake

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT07480109

Org study IDFP00012519

Timeline

Milestones

Study first posted2026-03-18actual

Study start2026-06-01actual

Last update posted2026-06-09actual

Primary completion2027-06-01estimated

Study completion2027-09-30estimated

Assets

Investigational agents

GLP-1 / incretin class catch-all

Who this study enrolls

Obesity / overweight

Who can enroll

Minimum age30 Years

Maximum age60 Years

SexFemale

Healthy volunteersAccepted

Inclusion criteria

•Adult women (30-60 years)

•Having overweight or obesity (BMI >25 kg/m2)

•Prescribed or taking GLP-1 medicine (within 4 weeks) by a physician

•Willing and able to maintain current inactivity patterns throughout the study

•Willing and able to follow all study procedures

•Generally healthy, as assessed from the medical history questionnaire

Exclusion criteria

•Adults (<30 years or >60 years)

•Having normal weight (BMI <25 kg/m2)

•Not prescribed GLP-1 medication by a physician

•Those on GLP-1 medication longer than 4 weeks (during time of screening)

•Currently on a high-protein or other specific diet

•Unwilling and/or unable to maintain current inactivity patterns throughout the study

•Unwilling and/or unable to follow all study procedures

•Unwilling and/or unable to eat pork (for the GLP-1 + Protein group)

•Not generally healthy, as assessed from the medical history questionnaire

Endpoints (11)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Other (unclassified)

Weight & body composition

Patient-reported / QoL

Weight & body composition

1 endpoint

Primary/protocol endpoint

Body Composition

Time frame:Baseline and 12 weeks

descriptive

Patient-reported / QoL

1 endpoint

Secondary/protocol endpoint

Health and Well-being Questionnaire

Time frame:Baseline and 12 weeks

descriptive

Other (unclassified)

9 endpoints

Primary/protocol endpoint/low confidence

Muscle Mass

Time frame:Baseline and 12 weeks

descriptive

Primary/protocol endpoint/low confidence

3-day Average Daily Intake

Time frame:Baseline and 12 weeks

descriptive

Secondary/protocol endpoint/low confidence

Energy Expenditure and Sleep

Time frame:Baseline and 12 weeks

descriptive

Secondary/protocol endpoint/low confidence

Food Noise

Time frame:Baseline, 2 week, 4 week, 6 week, 8 week, 10 week, 12 weeks

descriptive

Secondary/protocol endpoint/low confidence

Depression

Time frame:Baseline and 12 weeks

descriptive

Secondary/protocol endpoint/low confidence

Anxiety

Time frame:Baseline and 12 weeks

descriptive

Secondary/protocol endpoint/low confidence

Pork Consumption

Time frame:Baseline and 12 weeks

descriptive

Secondary/protocol endpoint/low confidence

Appetite, Satiety, Food Craving and Mood

Time frame:Baseline and 12 weeks

descriptive

Secondary/protocol endpoint/low confidence

Control of Eating

Time frame:Baseline and 12 weeks

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 6, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.